KIMS logo

Krishna Institute of Medical Sciences Limited Stock Price

NSEI:KIMS Community·₹323.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 26 Fair Values set on narratives written by author

KIMS Share Price Performance

₹811.10
811.10 (0.00%)
₹827.19
Fair Value
₹811.10
811.10 (0.00%)
1.9% undervalued intrinsic discount
₹827.19
Fair Value
Price ₹811.10
AnalystConsensusTarget ₹827.19
AnalystHighTarget ₹973.28
AnalystLowTarget ₹740.00

KIMS Community Narratives

·
Fair Value ₹827.19 1.9% undervalued intrinsic discount

New Facilities In India Will Unlock Rising Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
·
Fair Value ₹973.28 16.7% undervalued intrinsic discount

Rising Urbanization And Insurance Growth Will Expand Healthcare Access

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value ₹740 9.6% overvalued intrinsic discount

Urban Expansion Will Trigger Integration Risks And Regulatory Hurdles

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

KIMS logo

KIMS: Equity Issuance And Governance Changes Will Shape Balanced Forward Outlook

Fair Value: ₹740 9.6% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
KIMS logo

KIMS: Follow On Offering And Lock Up Period Will Shape Near-Term Outlook

Fair Value: ₹827.19 1.9% undervalued intrinsic discount
13 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
KIMS logo

KIMS: Planned Equity Raise And Lock Up Will Support Future Upside

Fair Value: ₹973.28 16.7% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Reasonable growth potential with very low risk.

2 Risks
1 Reward

Krishna Institute of Medical Sciences Limited Key Details

₹42.1b

Revenue

₹17.1b

Cost of Revenue

₹25.0b

Gross Profit

₹22.9b

Other Expenses

₹2.0b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
5.11
59.32%
4.85%
166.2%
View Full Analysis

About KIMS

Founded
1973
Employees
5264
CEO
Abhinay Bollineni
WebsiteView website
www.kimshospitals.com

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, diagnostic and imaging, ophthalmology, ENT, rheumatology and clinical immunology, internal medicine, interventional radiology, diabetology, endocrinology, general surgery, infectious disease, dermatology, thoracic surgery, psychiatry, plastic and reconstructive surgery, transfusion medicine, clinical psychology, anesthesiology, and tele medicine services. In addition, the company operates clinical immunology allergy, bone marrow transplantation, hair transplant, andrology, fertility, alzheimer, arthroscopy, bone and joint, breast, dialysis, female urology, IUI, IVF, joint replacement, kidney health and transplant, ICU, spine, stroke, TAVR/TAVI, hepatobiliary surgery, and trauma centers, as well as pain and wellness clinics. Further, it provides bariatric, thoracic, oral maxillofacial, and endovascular surgery services. Krishna Institute of Medical Sciences Limited was incorporated in 1973 and is based in Secunderabad, India.

Recent KIMS News & Updates

Analysis Article Aug 06

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krishna Institute of Medical Sciences Limited ( NSE:KIMS ) last week reported its latest first-quarter results, which...
Narrative Update Aug 05

KIMS: Equity Issuance And Governance Changes Will Shape Balanced Forward Outlook

Analysts have raised the fair value estimate for Krishna Institute of Medical Sciences to ₹740 from ₹695, citing updated assumptions that reflect the latest views on long term revenue growth, profit margins and future P/E expectations. What’s in the News for Krishna Institute of Medical Sciences Board meeting scheduled for 3 Aug 2026 to review and approve unaudited standalone and consolidated financial results for the quarter ended 30 Jun 2026.

Recent updates

No updates